Use of intermittent preventive treatment for malaria in pregnancy in a rural area of western Kenya with high coverage of insecticide-treated bed nets.
Kenya established intermittent preventive treatment (IPT) with sulfadoxine-pyrimethamine (SP) for malaria in pregnancy as national policy in 1998. We assessed the coverage of IPT among women who had recently delivered in a rural area of western Kenya with perennial malaria transmission and high coverage with insecticide treated nets (ITNs) through a cross-sectional, community-based survey in December 2002. Antenatal clinic (ANC) attendance was high (89.9% of the 635 participating women); 77.5% of attendees visited an ANC before the third trimester and 91.9% made more than one visit. Delivery of SP by the ANC was reported by 19.1% of all women but only 6.8% reported receiving more than one dose. Given the high rate of use of ANC services, if SP were given at each visit after the first trimester, the potential coverage of IPT (two doses of SP) would be 80.3% in this study population. ITNs were used by 82.4% of women during pregnancy, and almost all mothers (98.5%) who slept under an ITN shared the nets with their newborns after delivery. Women who thought malaria in pregnancy caused foetal problems were more likely to have used an ITN (adjusted odds ratio [AOR] 1.6, 95% confidence interval [CI] 1.0-2.4), and to have visited ANC more than once (AOR 2.4, 95% CI 1.2-4.7) compared to women who thought malaria in pregnancy was either not a problem or caused problems for the mother only. These findings illustrate the need for improved IPT coverage in this rural area. Identification and removal of the barriers to provision of IPT during ANC visits can help to increase coverage. In this area of Kenya, health messages stressing that foetal complications of malaria in pregnancy may occur in the absence of maternal illness may improve the demand for IPT.
van Eijk
A M
AM
Kenya Medical Research Institute, Centre for Vector Biology and Control Research, Kisumu, Kenya. AMvanEijk@yahoo.com
Blokland
I E
IE
Slutsker
L
L
Odhiambo
F
F
Ayisi
J G
JG
Bles
H M
HM
Rosen
D H
DH
Adazu
K
K
Lindblade
K A
KA
D000328:Adult; D000962:Antimalarials; D001512:Bedding and Linens; D003430:Cross-Sectional Studies; D004338:Drug Combinations; D019353:Endemic Diseases / Q000517:prevention & control; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007306:Insecticides; D007630:Kenya / Q000453:epidemiology; D016778:Malaria, Falciparum / Q000453:epidemiology / Q000517:prevention & control* / Q000523:psychology; D010342:Patient Acceptance of Health Care; D011159:Population Surveillance / Q000379:methods; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000453:epidemiology / Q000517:prevention & control* / Q000523:psychology; D011295:Prenatal Care / Q000379:methods; D011739:Pyrimethamine; D012423:Rural Health; D013413:Sulfadoxine
D000962:Antimalarials; D004338:Drug Combinations; D007306:Insecticides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine